Navigation Links
CeNeS in Medical Technology

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

CAMBRIDGE, England, 4th May 2007 - CeNeS Pharmaceuticals plc (LSE: CEN), the Cambridge based biopharmaceutical company, notes the publication of an independent study in the respected scientific journal 'Synapse'* on its Phase II NMDA antagonist, CNS 5161. CeNeS is developing CNS 5161 as a potentia...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

CAMBRIDGE, U.K. 2nd July 2007 - CeNeS Pharmaceuticals (AIM:CEN) ("CeNeS" or "the Company") the Cambridge-based biopharmaceutical company today announced that a paper published this week in CNS Drugs(1) further supports the hypothesis that a catechol-O-methyltransferase (COMT) inhibitor that acts i...

CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G

...rative pain CAMBRIDGE, England, 7th March 2007 - cenes Pharmaceuticals plc (AIM: CEN), the Cambridge base...ts The additional secondary data now received by cenes shows that: * less anti-emetic drugs (drugs used...mproved patient comfort due to lower PONV supports cenes justification of a substantial price premium for M...

CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006

...6G underway CAMBRIDGE, England, March 28, 2007 - cenes Pharmaceuticals plc ("CeNeS" or "the Company"), th...near-term." For more information please contact: cenes Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)12...n/Emma Thompson Tel: + 44 (0) 207 831 3113 About cenes Pharmaceuticals...

FDA approves IND on Lead Product M6G

... CAMBRIDGE, England, 26th April 2007 - cenes Pharmaceuticals plc (LSE: CEN), the Cambridge base...y analysis before progressing to Phase III trials. cenes is currently completing the protocol design of the...e therapy." For more information please contact: cenes Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)12...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

...pared to morphine Cambridge, UK, 8th June 2007 - cenes Pharmaceuticals plc (AIM: CEN), the Cambridge base...in market." For more information please contact: cenes Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)12...n/Emma Thompson Tel: + 44 (0) 207 831 3113 About cenes Pharmaceuticals...
Other Tags
(Date:7/29/2014)... (PRWEB) July 29, 2014 A team ... Professor Doug Ethell, PhD, has developed a blood test ... detection and the development of Alzheimer’s disease interventions, according ... disease is a puzzle, and this study represents one ... us over the past couple of years,” Ethell said. ...
(Date:7/29/2014)... Georgia (PRWEB) July 29, 2014 Just ... expanding offices to 4 new states, the exciting FX ... Special FX and one time farmboy from Arkansas, is ... of bringing innovative event technologies to the masses. ... the event packed island of Jamaica. This new ...
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Successful negotiations may ... men with wider faces may have an advantage, according to ... a broader face are more successful when negotiating for themselves ... facer may not be an asset when negotiations require collaboration ... whether we think about it or not. It,s not just ...
(Date:7/29/2014)... to drink alcohol brands that advertise on television programs ... and compelling evidence of a strong association between alcohol ... is the conclusion of a new study from the ... Johns Hopkins Bloomberg School of Public Health and the ... exposure to brand-specific alcohol advertising on 20 television shows ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 truBrain has ... fix provided by energy drinks. Think Drinks , ... nutrition that creates optimal conditions for memory, complex reasoning ... truBrain hopes to raise $50,000 over the course of ... stable mental boost and have compounding effects over time ...
Breaking Medicine News(10 mins):Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Atlanta Special FX Rapidly Expanding Just Opens First International Corporate Office in Jamaica 2Health News:Wider Face May Give You an Edge in Negotiations 2Health News:Brand-specific television alcohol ads predict brand consumption among underage youth 2Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2
(Date:7/28/2014)... additional coral communities showing signs of damage from the Deepwater ... spill in the Gulf of Mexico. The discovery was made ... at Penn State University. A paper describing this work and ... of Mexico will be published during the last week of ... Proceedings of the National Academy of Sciences . , ...
(Date:7/28/2014)... Essigmann and colleagues from the University of Washington had a ... could induce the virus to mutate uncontrollably, they could force ... that our immune system uses against many viruses. , ... mutate at an enhanced rate, as expected. But it did ... trial reported in 2011. In a new study, however, Essigmann ...
(Date:7/28/2014)... Alzheimer,s disease and other forms of dementia, but the ... , University of Washington bioengineers have a designed a ... the body,s normal proteins into a state that,s linked ... Type 2 diabetes and Lou Gehrig,s disease. The synthetic ... normal state into an abnormally folded form by targeting ...
Breaking Biology News(10 mins):Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3
Other Contents